In summary, our data showed that the shorter survival of patients with CRC characterized by high NMUR1 expression is mediated by the effect of CRC-secreted NMU and its pro-metastatic activation of NMUR1-positive cancer cells, as well as tumour-infiltrating macrophages, endothelial cells and platelets. The gene discussed is NMUR1; the disease is colorectal carcinoma.